{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:48:14Z","timestamp":1793332094834,"version":"4.5.0"},"reference-count":29,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Although it is generally held that in otherwise healthy individuals, primary hyperparathyroidism is the most likely cause of persistent hypercalcemia, solid research supporting this assumption is absent. We aimed to examine the relative and absolute risk of primary hyperparathyroidism associated with an incidental high ionized calcium in the general population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used the Danish Copenhagen General Population Study, a prospective cohort study with inclusion in 2003-2015, to investigate the association of ionized calcium on continuous and categorical scales with primary hyperparathyroidism using Cox regression and competing-risk regression. Hazard ratios and absolute 10-year risks of primary hyperparathyroidism were calculated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In 106 588 individuals, 2497 (2.5%) had moderately high (1.33-1.40\u2005mmol\/L) or high (&amp;gt;1.40\u2005mmol\/L) plasma ionized calcium at baseline and 441 (0.4%) were diagnosed with primary hyperparathyroidism during follow-up. The multivariable adjusted hazard ratios for primary hyperparathyroidism for moderately high and high plasma ionized calcium vs low normal ionized calcium were 65 (95% confidence interval: 46-92) and 350 (251-489). Stratified on sex, the corresponding hazard ratios were 63 (42-95) and 326 (221-482) for women and 73 (37-145) and 490 (256-935) for men. For women and men above 65 years, absolute risks of primary hyperparathyroidism were 7.9% and 3.3% in those with moderately high plasma ionized calcium and 44% and 21% in those with high plasma ionized calcium.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>High ionized calcium found in 1:40 in the general population conferred absolute 10-year risks of primary hyperparathyroidism of up to 44%. These findings support further diagnostic workup following an incidentally observed high plasma ionized calcium in otherwise healthy individuals.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf106","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T03:36:16Z","timestamp":1740022576000},"page":"e3878-e3885","source":"Crossref","is-referenced-by-count":2,"title":["High Ionized Calcium in the General Population and Risk of Primary Hyperparathyroidism"],"prefix":"10.1210","volume":"110","author":[{"given":"Camilla J","family":"Kobylecki","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev Gentofte , 2730 Herlev ,","place":["Denmark"]},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev Gentofte , 2730 Herlev ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G","family":"Nordestgaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev Gentofte , 2730 Herlev ,","place":["Denmark"]},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev Gentofte , 2730 Herlev ,","place":["Denmark"]},{"name":"Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1442-4694","authenticated-orcid":false,"given":"Shoaib","family":"Afzal","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev Gentofte , 2730 Herlev ,","place":["Denmark"]},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev Gentofte , 2730 Herlev ,","place":["Denmark"]},{"name":"Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"11","key":"2025101519581462200_dgaf106-B1","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025101519581462200_dgaf106-B2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/02813430600784443","article-title":"Diagnosis of patients with raised serum calcium level in primary care, Sweden","volume":"24","author":"Dalemo","year":"2006","journal-title":"Scand J Prim Health Care"},{"issue":"6","key":"2025101519581462200_dgaf106-B3","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record","volume":"154","author":"Press","year":"2013","journal-title":"Surgery"},{"issue":"3","key":"2025101519581462200_dgaf106-B4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025101519581462200_dgaf106-B5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/SLA.0000000000002370","article-title":"Failure to diagnose hyperparathyroidism in 10,432 patients with hypercalcemia: opportunities for system-level intervention to increase surgical referrals and cure","volume":"266","author":"Balentine","year":"2017","journal-title":"Ann Surg"},{"issue":"9","key":"2025101519581462200_dgaf106-B6","doi-asserted-by":"crossref","first-page":"e828","DOI":"10.1634\/theoncologist.2018-0424","article-title":"Failure to diagnose and treat hyperparathyroidism among patients with hypercalcemia: opportunities for intervention at the patient and physician level to increase surgical referral","volume":"24","author":"Asban","year":"2019","journal-title":"Oncologist"},{"issue":"1","key":"2025101519581462200_dgaf106-B7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.surg.2019.06.044","article-title":"Derivation of a cost-saving screening strategy for asymptomatic primary hyperparathyroidism","volume":"167","author":"Nguyen-Lee","year":"2020","journal-title":"Surgery"},{"issue":"1\u20132","key":"2025101519581462200_dgaf106-B8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.0954-6820.1976.tb08208.x","article-title":"Prevalence of hypercalcaemia in a health screening in Stockholm","volume":"200","author":"Christensson","year":"1976","journal-title":"Acta Med Scand"},{"issue":"1","key":"2025101519581462200_dgaf106-B9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2362.1988.tb01163.x","article-title":"Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values","volume":"18","author":"Palmer","year":"1988","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"2025101519581462200_dgaf106-B10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","article-title":"Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women","volume":"121","author":"Lundgren","year":"1997","journal-title":"Surgery"},{"issue":"11","key":"2025101519581462200_dgaf106-B11","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0895-4356(00)00239-0","article-title":"Primary hyperparathyroidism detected in a health screening. The Tromso study","volume":"53","author":"Jorde","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2025101519581462200_dgaf106-B12","doi-asserted-by":"crossref","first-page":"e2248332","DOI":"10.1001\/jamanetworkopen.2022.48332","article-title":"Analysis of time to diagnosis and outcomes among adults with primary hyperparathyroidism","volume":"5","author":"Lorenz","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2025101519581462200_dgaf106-B13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0021-9258(18)75414-8","article-title":"A biological method for the estimation of calcium ion concentration","volume":"107","author":"McLean","year":"1934","journal-title":"J Bio Chem"},{"issue":"3","key":"2025101519581462200_dgaf106-B14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/00365518909089086","article-title":"Comparison of serum total calcium, albumin-corrected total calcium, and ionized calcium in 1213 patients with suspected calcium disorders","volume":"49","author":"Thode","year":"1989","journal-title":"Scand J Clin Lab Invest"},{"issue":"10\u201311","key":"2025101519581462200_dgaf106-B15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.clinbiochem.2011.04.002","article-title":"Biochemical diagnosis of primary hyperparathyroidism: analysis of the sensitivity of total and ionized calcium in combination with PTH","volume":"44","author":"Nordenstrom","year":"2011","journal-title":"Clin Biochem"},{"issue":"9","key":"2025101519581462200_dgaf106-B16","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/jc.2012-1429","article-title":"The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism","volume":"97","author":"Ong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025101519581462200_dgaf106-B17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.amjsurg.2013.01.017","article-title":"Ionized vs serum calcium in the diagnosis and management of primary hyperparathyroidism: which is superior?","volume":"205","author":"Tee","year":"2013","journal-title":"Am J Surg"},{"issue":"4","key":"2025101519581462200_dgaf106-B18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jalm\/jfaa006","article-title":"Evaluation of a new automated routine measurement for serum adjusted ionized calcium (at pH 7.4) in patients suspected of calcium metabolic disease","volume":"5","author":"Kur","year":"2020","journal-title":"J Appl Lab Med"},{"issue":"5","key":"2025101519581462200_dgaf106-B19","doi-asserted-by":"crossref","first-page":"e1001212","DOI":"10.1371\/journal.pmed.1001212","article-title":"The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach","volume":"9","author":"Nordestgaard","year":"2012","journal-title":"PLoS Med"},{"issue":"18","key":"2025101519581462200_dgaf106-B20","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"359","author":"Zacho","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"2025101519581462200_dgaf106-B21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/clinchem\/36.3.541","article-title":"Adjusted ionized calcium (at pH 7.4) and actual ionized calcium (at actual pH) in capillary blood compared for clinical evaluation of patients with disorders of calcium metabolism","volume":"36","author":"Thode","year":"1990","journal-title":"Clin Chem"},{"issue":"4","key":"2025101519581462200_dgaf106-B22","first-page":"147","article-title":"Recommendation on sampling, transport, and storage for the determination of the concentration of ionized calcium in whole blood, plasma, and serum. IFC Scientific Division, Working Group on Ion-Selective Electrodes (WGSE)","volume":"4","author":"Boink","year":"1992","journal-title":"J Int Fed Clin Chem"},{"issue":"11","key":"2025101519581462200_dgaf106-B23","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025101519581462200_dgaf106-B24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2025101519581462200_dgaf106-B25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4612-1694-0_15","volume-title":"Selected Papers of Hirotugu Akaike","author":"Akaike","year":"1998"},{"issue":"446","key":"2025101519581462200_dgaf106-B26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"16","key":"2025101519581462200_dgaf106-B27","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2022.18331","article-title":"Hypercalcemia: a review","volume":"328","author":"Walker","year":"2022","journal-title":"JAMA"},{"issue":"10116","key":"2025101519581462200_dgaf106-B28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"2025101519581462200_dgaf106-B29","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/jbmr.4682","article-title":"Management of primary hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf106\/62006544\/dgaf106.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/11\/e3878\/62006544\/dgaf106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/11\/e3878\/62006544\/dgaf106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T23:58:19Z","timestamp":1760572699000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/11\/e3878\/8026078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,2,20]]},"published-print":{"date-parts":[[2025,10,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf106","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,2,20]]}}}